Skip to content

The treatment of Bacterial Vaginosis with Amla

Efficacy of Amla (Emblica officinalis) in Bacterial Vaginosis: A Randomized Standard Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044470
Enrollment
40
Registered
2022-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

Intervention1: Amla (Emblica officinalis) with honey: Powder of Amla (4 gm) with honey (5 ml) will be given orally twice daily for 4 weeks Follow up 15th and 29th day Control Intervention1: Tablet Met

Sponsors

Luqman Unani Medical college and Research center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married women between 18 to 40 years of age with complaints of foul smelling vaginal discharge low backache and lower abdominal pain 2 Positive Amsels criteria

Exclusion criteria

Exclusion criteria: 1 Pregnant lactating and menopausal women 2 Patients having sexually transmitted diseases and unhealthy cervix 3 Recent use of systemic or local antibiotics in the past 2 weeks 4 Patients with known systemic and metabolic illnesses 5 Diagnosed with organic pelvic pathology and malignancy 6 Patient using IUCDs and OCPs

Design outcomes

Primary

MeasureTime frame
1) Changes in foul smelling vaginal discharge, low backache and lower abdominal pain assessed on VAS scale 2) Change in Amsels criteria scoreTimepoint: All outcomes will only be measured at baseline and after completion of the treatment.

Secondary

MeasureTime frame
Change in quality of life will be assessed on SF12 questionnaire.Timepoint: At baseline and after completion of the trial.

Countries

India

Contacts

Public ContactDr Nikhat Kausar Inamdar

Luqman Unani Medical college and Research center

aqilquadri@yahoo.com9849090182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026